Randomized clinical trial: Dapagliflozin after TAVI https://nitter.cf/t.co/MnBktYqgGE Identifier: NCT0469618 Eur J Heart Fail. 2022;24(3):581-588 @CNIC_CARDIO @secardiologia
Joined November 2020
- Tweets1.5K
- Following4.8K
- Followers1.8K
- Likes205
DapaTAVI retweeted
A new DapaTAVI publication by @rafaelglezm
Dapagliflozin after TAVI in frail patients
Great paper in @JAHA_AHA ahajournals.org/doi/10.1161/…
@S_Raposeiras @Borjaibanez1 @ignamatsant
@secardiologia @CNIC_CARDIO @clinica_sec
DapaTAVI retweeted
Wondering whether to prescribe dapagliflozin to frail patients at high risk of HF after TAVI?🤔
📖Read our latest @DapaTAVI substudy, just out in @JAHA_AHA
ahajournals.org/doi/10.1161/…
A new DapaTAVI publication by @rafaelglezm
Dapagliflozin after TAVI in frail patients
Great paper in @JAHA_AHA ahajournals.org/doi/10.1161/…
@S_Raposeiras @Borjaibanez1 @ignamatsant
@secardiologia @CNIC_CARDIO @clinica_sec
New @DapaTAVI publication led by @BonanadClara Sergio García @rafaelglezm @S_Raposeiras
Amazing paper in JACC
@Borjaibanez1 @ignamatsant
@secardiologia @CNIC_CARDIO @clinica_sec
jacc.org/doi/10.1016/j.jacc.…
New paper from @DapaTAVI
Great job @RosselloXavier and @rafaelglezm
Come on
@S_Raposeiras @Borjaibanez1 @ignamatsant
@secardiologia @CNIC_CARDIO @clinica_sec
@RevEspCardiol
pubmed.ncbi.nlm.nih.gov/4097…
@DapaTAVI trial in #ESCCongress
Sunday 31 at 9 am, presentation by @Borjaibanez1
Come on!!!!!!!!!!
@secardiologia @CNIC_CARDIO @clinica_sec @S_Raposeiras
DapaTAVI retweeted
🔥#HeartFailure2025 #LBCT #DapaTAVI Quality of Life
#SGLT2i dapa in severe AS undergoing TAVI
Main paper @NEJM ↓ deaths & worsening HF:
nejm.org/doi/full/10.1056/NE…
New LBCT @BonanadClara curiously no incremental gains in QOL
Great reporting by @ToddNeale: tctmd.com/news/no-additional…
DapaTAVI retweeted
Es un placer presentar en los Podcast el DAPA-TAVI Trial @DapaTavi , presentado por el Dr. @S_Raposeiras . @secardiologia @shci_sec @ResisCardioVigo @fundacionepic @foroepic @JuradoRomanAl @pipecardio @Felipediezhoyo @CACIarg @solaci_online
Felicitaciones por este trabajo independiente con auspicio de SEC.
Lo pueden ver en mi canal de Youtube.
Suscribanse para verlo
youtu.be/4pL4n7RFLVo?si=qgVs…
DapaTAVI retweeted
📢 ABRIMOS HILO
1/ La cardiología española sigue marcando hitos en la investigación. El estudio @DapaTavi , publicado en @NEJM , demuestra que un fármaco para la diabetes mejora el pronóstico en pacientes con TAVI. 🫀💊👇 #DAPAKODURO
DapaTAVI retweeted
📰 @DapaTavi 👉 SGLT2i improves outcomes after #TAVI. medpagetoday.com/meetingcove… | Vía @medpagetoday ✍️ @cphend
DapaTAVI retweeted
🔬 Investigadores españoles del @CNIC_CARDIO y del Hospital Universitario Álvaro Cunqueiro de Vigo demuestran que un fármaco para la #diabetes mejora el pronóstico de pacientes sometidos a intervención valvular cardiaca.
💊#Dapagliflozina redujo la tasa de muerte o de ingreso por #InsuficienciaCardiaca según los resultados del estudio @DapaTavi realizado en 1.250 pacientes y coordinado por @Borjaibanez1.
DOI 📄 doi.org/10.1056/NEJMoa250036… #OpenAccess 🔓 @NEJM
#Ciencia #CNIC #InvestigaciónCardiovascular
DapaTAVI retweeted
DapaTAVI Trial: Dapagliflozin significantly reduced mortality and heart failure worsening in high-risk older adults undergoing transcatheter aortic valve implantation (TAVI). Among patients with heart failure and additional comorbidities—such as renal insufficiency, diabetes, or left ventricular systolic dysfunction—the SGLT2 inhibitor lowered the 1-year risk of all-cause death or heart failure–related hospitalization/urgent care compared to standard therapy (15.0% vs 20.1%; HR 0.72, 95% CI 0.55–0.95; P=0.02).
#ACC25
DapaTAVI retweeted
#ACC2025 @CRT_meeting @TCTMD @PCRonline
#DAPATAVI
"Among older adults with aortic stenosis undergoing #TAVI who were at high risk for heart-failure events, dapagliflozin resulted in a significantly lower incidence of death from any cause or worsening of heart failure than standard care alone."
nejm.org/doi/full/10.1056/NE…
#ACC2025 @CRT_meeting @TCTMD @PCRonline @news_hart
"The #STRIDE trial enrolled participants with symptomatic PAD and T2D. Semaglutide improve walking distance!"
DapaTAVI retweeted
Catch me blasting #DAPAKUDURO for the rest of this conference. Such a great presentation and impressive results! Another win for SGLT2i, and importantly, in the elderly population
#ACC25 #DAPATAVI
DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk ↘️. #ACC25
More: bit.ly/3DOlxJ8 #cvSurg
DapaTAVI retweeted
NEJM Editorial Fellow Sarah Gorey, MD (@sarah_gorey), summarizes the DapaTAVI trial.
DapaTAVI retweeted
#DAPATAVI #ACC25
Among older adults with aortic stenosis undergoing TAVI who were at⬆️ risk for heart-failure, dapagliflozin resulted in a significantly lower incidence of death from any cause or worsening of heart failure than standard care alone
📎 nejm.org/doi/full/10.1056/NE…
Well this was something something else!#DAPATAVI presented at #ACC25 like a movie with music! This was a Hollywood production!!
Congratulations on the study and the findings. Congratulations on the creativity
#cardiotwitter #LBCT
DapaTAVI retweeted
L’estudi espanyol #DapaTAVI mostra que en els pacients a qui s’ha implantat TAVI, la dapagliflozina va reduir la incidència de mort per qualsevol causa o empitjorament de la insuficiència cardíaca @NEJM @S_Raposeiras @Borjaibanez1 @CNIC_CARDIO @AnderRegueiro #ACC25
Presented at #ACC25:
Among older patients undergoing TAVI, dapagliflozin led to a lower incidence of a composite of death from any cause or worsening of heart failure than standard care at 1 year. Full DapaTAVI trial results: nej.md/4kSIc7L
Editorial: Aortic Stenosis — When Valve Intervention Is Not Enough nej.md/4l04Fjj
@ACCinTouch
ALT A graph showing the time until the composite primary outcome of death from any cause or worsening of heart failure; the latter was defined as either an unplanned hospitalization or an urgent medical visit.
DapaTAVI retweeted
Dr. Bhatt’s comment on the “DAPA-TAVI” dance was absolutely hilarious 😂🕺
nejm.org/doi/full/10.1056/NE…
@DapaTavi
nitter.cf/NEJM/status/1906052498…
#ACC25 #25JCS
Presented at #ACC25:
Among older patients undergoing TAVI, dapagliflozin led to a lower incidence of a composite of death from any cause or worsening of heart failure than standard care at 1 year. Full DapaTAVI trial results: nej.md/4kSIc7L
Editorial: Aortic Stenosis — When Valve Intervention Is Not Enough nej.md/4l04Fjj
@ACCinTouch
ALT A graph showing the time until the composite primary outcome of death from any cause or worsening of heart failure; the latter was defined as either an unplanned hospitalization or an urgent medical visit.